Key facts
- Notable investors include Brabantse Ontwikkelings Maatschappij, Bank of Maharashtra, Horizon 2020, Locapes Investment Fund, Value Creation Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for InProcess-LSP
- ·The full record, as it builds
Funding rounds
No funding rounds for InProcess-LSP are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About InProcess-LSP
Developer of a process analytical device designed for nanoparticle size analysis. The company's device offers real-time, non-invasive measurement of particle size and size distribution in turbid nanosuspensions without the need for sample treatment or dilution, enabling pharmaceutical and biopharmaceutical industries to enhance process efficiency, ensure product quality, and reduce development time.
- Sector
- Healthcare
- HQ
- Oss, Netherlands
- Founded
- 2014
- Employees
- 17
- Website
- inprocess-lsp.com/
- Ownership
- Privately Held (backing)
InProcess-LSP doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in InProcess-LSP shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on InProcess-LSP in its N-PORT filings yet. We sweep new filings monthly.